{"disease":{"id":"egfr-her2-exon-20-insertion-mutation","name":"egfr her2 exon 20 insertion mutation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06043817","title":"First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":251,"lead_sponsor_name":"Pierre Fabre Medicament","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}